Micro Emerging Active

UBS rozpoczyna śledzenie Jasper Therapeutics

New narrative with limited coverage — still forming.

Ocena
0,4
Dynamika
▲ 0,0
Artykuły
4
Źródła
1

Sentiment Timeline

Event Timeline

Kwi 07, 2026
Evercore ISI Lowers its Price Target on Jasper Therapeutics (JSPR) to $7 Bearish
Kwi 06, 2026
UBS Upgrades JFrog (FROG) to Buy with $60 Price Target on Demand … Bullish
Mar 30, 2026
Edgewise Therapeutics, Inc. (EWTX) PT Increased to $45 at JPMorgan Amid Optimism … Bullish
Mar 29, 2026
Why UBS Started Jasper Therapeutics (JSPR) at Neutral Despite Progress in Briquilimab Neutral

Oś czasu

Pierwsze pojawienieMar 29, 2026
Ostatnia aktualizacjaMar 29, 2026